-DNA Joining ranks with nearly ten other big states, Gujarat government has now decided not to allow field trials of any Genetically Modified (GM) food crops within its boundaries. The decision is a significant one as it comes from the home state of prime minister Narendra Modi which he was leading till few months ago. Now with Gujarat also saying no to field trials of GM crops, Maharashtra remains the only state...

-The Times of India A paragraph buried in the US-India joint statement, which talks of establishing an annual high-level Intellectual Property (IP) working group as part of the Trade Policy Forum, has made health activists across the world apprehensive that the Modi government might be bending to US pressure to change its patent laws. Several health policy experts and activists have issued statements urging India not to give in to US...

-The Hindustan Times By his own admission, Prime Minister Narendra Modi is "happiest" showing the door to laws that are of no use. Accordingly, his government has put in motion a plan to repeal as many as 987 obsolete laws. The law ministry will bring a new bill in the winter session of Parliament to repeal 287 obsolete laws and junk about 700 Appropriation Acts that have lost...

-Press Information Bureau/ Ministry of Housing and Urban Poverty Alleviation The Government today announced an overarching scheme for uplift of urban and rural poor through enhancement of livelihood opportunities through skill development and other means. The scheme has been named as ‘Deen Dayal Antyodaya Yojana - DAY'. The announcement was made today by Shri M.Venkaiah Naidu, Minister of Housing & Urban Poverty Alleviation and Shri Nitin Gadkari, Minister of Rural Development...

-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...